Protect Pregnancy and Breastfeeding-Do No Harm

Protect Pregnancy and Breastfeeding-Do No Harm

The precautionary principle demands that we err on the side of caution when there are unknown risks for a given medical product. This is especially true for pregnant and breastfeeding women who must consider not only themselves, but the impact on their developing fetus or child.

An international panel of pregnancy, birthing and breastfeeding experts join together to create resources to empower pregnant and breastfeeding women to make informed choices.

The following resources are prepared by CCCA and Mama Bears Project.

Ready Resources

In this short video, women are encouraged to be more critical in assessing their need for vaccines during pregnancy and while breastfeeding by asking for evidence that safety has been proven, that the product is indeed necessary, and if its claimed benefits have actually been proven.

Use this shareable infographic to encourage pregnant and breastfeeding mothers to ask questions about medical products they may be recommended to use. The mRNA products have not been proven safe for this group, and without appropriate safety data, mothers and mothers-to-be cannot make knowledgeable informed choices. The QR code directs the reader to our campaign home page.

This resource guide is the collaborative effort of the CCCA and international experts in the fields of pregnancy, birthing, and breastfeeding. This document uses evidence-based research to frame the ethical and medical considerations of the use of undertested medical products during pregnancy and breastfeeding. History has taught us that the precautionary principle must always be used when using medical interventions during these vulnerable periods.

RSV Vaccination and the Pharma Playbook

A fundamental tenet of health care is – “First, do no harm”. This principle must never be compromised when caring for pregnant mothers. To minimize probable harmful exposure and consequences to the mom and baby, women have been encouraged to avoid medications during pregnancy. It is an ethical and moral imperative that drugs administered during pregnancy must have an established safety record and be of proven therapeutic value. This article, written by members of the CCCA’s Scientific and Medical Advisory Committee (SMAC), reviews the tactics used by the pharmaceutical industry to increase the chances of vaccine approval and uptake by pregnant women for the RSV vaccine. An awareness of such promotional strategies allows mothers and healthcare providers to critically assess the need for therapeutic products being promoted during pregnancy and breastfeeding. 

What's New

Deanna McLeod and veteran midwife Mary Sharpe were interviewed on The New American show.

Many expectant and new parents feel overwhelmed with information and even pressures to make certain medical choices. It is natural to have questions and you should feel comfortable asking them. This guide directs readers to resources in the Protect Pregnancy and Breastfeeding Campaign that answer some questions they may have. Use this resource to help open discussion with your healthcare provider regarding the indications COVID-19 mRNA injections so you are able to make informed choices.

Deanna McLeod discusses the importance of the precautionary principle when considering therapeutic products during pregnancy and breastfeeding. She describes the shift from proving safety before authorization during these vulnerable periods. This is particularly concerning considering the COVID-19 genetic vaccines qualify as gene therapy.

The Protect Pregnancy and Breastfeeding Campaign team have written a letter to Healthcare Professionals directing them to the resources available on their campaign page. The campaign resources assist healthcare providers weigh the relevant data so they may help expectant and new parents make informed choices about medical therapies. Healthcare providers are an integral link to necessary health resources, so it is important for expectant and new mothers to feel comfortable asking questions.

Weighing the Evidence: A Response to the COVID-19 Immunity Task Force COVERED Study